Application 091206
- Type
- ANDA
- Sponsor
- PLIVA HRVATSKA DOO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BIVALIRUDIN | BIVALIRUDIN | INJECTABLE;INTRAVENOUS | 250MG/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BIVALIRUDIN | BIVALIRUDIN | Eugia US LLC | e574d04f-67b4-4a84-9d66-8c2d54f95120 | 2026-07-10 | Warnings, Adverse reactions | BIVALIRUDIN BIVALIRUDIN |
| bivalirudin | BIVALIRUDIN | Civica, Inc. | 19a4afc5-151d-4d3c-bfef-48aa8797d695 | 2025-09-10 | Warnings, Adverse reactions | bivalirudin BIVALIRUDIN |
| Bivalirudin | BIVALIRUDIN | Fresenius Kabi USA, LLC | 50975be1-6d1f-497c-b989-1825a0fae1a7 | 2025-08-27 | Warnings, Adverse reactions | Bivalirudin BIVALIRUDIN |
| Bivalirudin | BIVALIRUDIN | Fresenius Kabi USA, LLC | af943fa0-ab0f-4b62-9ff0-54ee24cdb772 | 2025-05-08 | Warnings, Adverse reactions | Bivalirudin BIVALIRUDIN |
| Bivalirudin | BIVALIRUDIN | Mylan Institutional LLC | 95d150e7-f152-4091-b831-e469c9578a54 | 2025-03-24 | Warnings, Adverse reactions | Bivalirudin BIVALIRUDIN |
| Bivalirudin | BIVALIRUDIN | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 61de12ff-e280-4bab-9804-43869ec45fa7 | 2024-12-23 | Warnings, Adverse reactions | Bivalirudin BIVALIRUDIN |
| Bivalirudin | BIVALIRUDIN | Accord Healthcare, Inc. | c20969cb-72d4-469b-9bd8-332250d896c3 | 2024-08-15 | Warnings, Adverse reactions | Bivalirudin BIVALIRUDIN |
| Bivalirudin | BIVALIRUDIN | MAIA Pharmaceuticals, Inc. | c727199d-f4cd-4658-8fdf-568590beface | 2024-05-27 | Warnings, Adverse reactions | Bivalirudin BIVALIRUDIN |
| BIVALIRUDIN | BIVALIRUDIN | Meitheal Pharmaceuticals Inc. | 26fb46f6-0088-42b8-b6f2-c67224776803 | 2024-04-04 | Warnings, Adverse reactions | BIVALIRUDIN BIVALIRUDIN |
| Bivalirudin | BIVALIRUDIN | Par Health USA, LLC | 91cf9d00-29e0-4357-a184-f70026c47edb | 2024-03-01 | Warnings, Adverse reactions | Bivalirudin BIVALIRUDIN |
| Bivalirudin | BIVALIRUDIN | Avenacy, Inc. | 42aa2630-83d6-433d-8277-0f672cf8d71d | 2023-10-20 | Warnings, Adverse reactions | Bivalirudin BIVALIRUDIN |
| bivalirudin | BIVALIRUDIN | Slate Run Pharmaceuticals, LLC | 5d9a45c6-e234-4d56-9132-5e24e65852e6 | 2021-06-09 | Warnings, Adverse reactions | bivalirudin BIVALIRUDIN |
| BIVALIRUDIN | BIVALIRUDIN | Meitheal Pharmaceuticals Inc. | 4119b710-ef30-4e3e-b99a-38e42b4b3fca | 2021-06-08 | Warnings, Adverse reactions | BIVALIRUDIN BIVALIRUDIN |
| bivalirudin | BIVALIRUDIN | Sandoz Inc | ce56f806-7845-429d-a1ce-c2dbf79b22eb | 2019-09-30 | Warnings, Adverse reactions | bivalirudin BIVALIRUDIN |
| Bivalirudin | BIVALIRUDIN | Dr. Reddy's Laboratories Limited | 19beb2ae-6064-3c24-fe50-0cee86896979 | 2019-07-16 | Warnings, Adverse reactions | Bivalirudin BIVALIRUDIN |